Explore

Trendline Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Trendline Trendline
Savara Reports Increased Losses in Q1 2026 Amid Regulatory Milestones for MOLBREEVI

Savara Reports Increased Losses in Q1 2026 Amid Regulatory Milestones for MOLBREEVI

Savara Reports Increased Losses in Q1 2026 Amid Regulatory Milestones for MOLBREEVI
Trendline Trendline
Immunome Submits NDA for Varegacestat and Reports Financial Results

Immunome Submits NDA for Varegacestat and Reports Financial Results

Immunome Submits NDA for Varegacestat and Reports Financial Results
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances
Trendline Trendline
PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials

PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials

PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials
Trendline Trendline
Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Takeda Reports FY2025 Results and FY2026 Outlook with Strong Pipeline Progress

Takeda Reports FY2025 Results and FY2026 Outlook with Strong Pipeline Progress

Takeda Reports FY2025 Results and FY2026 Outlook with Strong Pipeline Progress
Trendline Trendline
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials

Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials

Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Trendline Trendline
Coya Therapeutics Reports Financial Results and Advances ALS Treatment

Coya Therapeutics Reports Financial Results and Advances ALS Treatment

Coya Therapeutics Reports Financial Results and Advances ALS Treatment
Trendline Trendline
Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment

Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment

Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment